Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liala Moschetti

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Early Human Development|March 26, 2024
Neurodevelopmental profile in children born to mothers affected by systemic sclerosisJessica Galli, Erika Loi, Maria Grazia Lazzaroni, et al.
Rheumatology (Oxford, England)|November 14, 2025
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centersLiala Moschetti, Savino Sciascia, Micaela Fredi, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple PregnanciesChiara Orlandi, Angela Tincani, Micaela Fredi, et al.
Clinical Reviews in Allergy & Immunology|January 18, 2022
Reproductive Issues and Pregnancy Implications in Systemic SclerosisMaria-Grazia Lazzaroni, Francesca Crisafulli, Liala Moschetti, et al.
Rheumatology (Oxford, England)|November 29, 2020
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositisMarco Fornaro, Francesco Girolamo, Lorenzo Cavagna, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centresLiala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Early Human Development|March 26, 2024
Neurodevelopmental profile in children born to mothers affected by systemic sclerosisJessica Galli, Erika Loi, Maria Grazia Lazzaroni, et al.
Rheumatology (Oxford, England)|November 14, 2025
Primary antiphospholipid syndrome and the kidney: biopsy-proven insights from two referral Italian centersLiala Moschetti, Savino Sciascia, Micaela Fredi, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple PregnanciesChiara Orlandi, Angela Tincani, Micaela Fredi, et al.
Clinical Reviews in Allergy & Immunology|January 18, 2022
Reproductive Issues and Pregnancy Implications in Systemic SclerosisMaria-Grazia Lazzaroni, Francesca Crisafulli, Liala Moschetti, et al.
Rheumatology (Oxford, England)|November 29, 2020
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositisMarco Fornaro, Francesco Girolamo, Lorenzo Cavagna, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centresLiala Moschetti, Luisa Dal Pozzolo, Veronique Le Guern, et al.
Rheumatology (Oxford, England)|April 8, 2026
Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR databaseAslihan Avanoglu-Guler, Michael Hughes, Giacomo De Luca, et al.
Therapeutic Advances in Musculoskeletal Disease|March 5, 2026
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohortLiala Moschetti, Silvia Rovaris, Francesco Bonomi, et al.
Current Pharmaceutical Design|September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing TreatmentsClodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design|June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing TherapiesClodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Pageof 2